Development of Glucose Intolerance in Wistar Rats Fed Low and Moderate Fat Diets Differing in Fatty Acid Profile

Abstract

Background/Aims: Both dietary fat content and fatty acid composition play a role in the development of glucose intolerance and insulin resistance. In this study we investigated the effect of moderate increases in dietary fat (10–30% of fat as total calories) and associated differences in fatty acid content, on the development of metabolic perturbations in the Wistar rat.

Methods: Eighteen normal male Wistar rats were randomly divided into 3 groups (n=6 each) at weaning, and fed different diets for 10 months: D10–10% fat as energy; D20–20% fat as energy and D30–30% fat as energy ad libitum.

Results: Compared with D10, rats fed D20 and D30 exhibited increased body weight from as early as 1 month of the study (p<0.01). None of the diets resulted in hyperglycemia, but glucose intolerance developed as early as 1 month in the D20 and D30 groups (p<0.01) following intravenous glucose tolerance test. Over time, the glucose stimulated insulin secretion rate (GSIS) became more blunted in the D20 and D30 groups, but by 10 months the D20 group regained some insulin responsiveness. D30 showed very poor GSIS at 10 months indicating glucose intolerance. Plasma ω6 and ω3 fatty acid profiles mostly reflected the dietary content, but the ratio of ω6:ω3 in plasma deteriorated over time in D30, whereas that of D10 and D20 improved.

Conclusion: A moderate increase in dietary fat (20%), within the recommended nutritional range, and an unfavourable ω6:ω3 ratio resulted in glucose intolerance in this Wistar rat model, which was exacerbated with a further increase in dietary fat (30%).

Key words

fatty acids - insulin resistance - dietary fat

References

• 1 ADA . Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.  Diabetes Care. 2007;  30 ((1)) S48-S65
• 2 Ailhaud G, Massiera F, Weill P. et al . Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity.  Prog Lipid Res. 2006;  45 ((3)) 203-236
• 3 Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.  Diabetes. 1997;  46 ((1)) 3-10
• 4 Bonora E, Bonadonna RC, Del Prato S. et al . In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.  Diabetes. 1993;  42 ((5)) 764-772
• 5 Borkman M, Storlien LH, Pan DA. et al . The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids.  N Engl J Med. 1993;  328 ((4)) 238-244
• 6 Buettner R, Newgard CB, Rhodes CJ. et al . Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.  Am J Physiol Endocrinol Metab. 2000;  278 ((3)) E563-E569
• 7 Buettner R, Ottinger I, Scholmerich J. et al . Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis.  Am J Physiol Endocrinol Metab. 2004;  286 ((5)) E828-E833
• 8 Buettner R, Parhofer KG, Woenckhaus M. et al . Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.  J Mol Endocrinol. 2006;  36 ((3)) 485-501
• 9 Carpentier A, Mittelman SD, Bergman RN. et al . Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.  Am J Physiol Endocrinol Metab. 1999a;  276 ((6)) E1055-E1066
• 10 Carpentier A, Mittelman SD, Lamarche B. et al . Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.  Am J Physiol. 1999b;  276 ((6 Pt 1)) E1055-E1066
• 11 Coll T, Eyre E, Rodriguez-Calvo R. et al . Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells.  J Biol Chem. 2008;  283 ((17)) 11107-11116
• 12 Escriva F, Gavete ML, Fermin Y. et al . Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity.  J Endocrinol. 2007;  194 ((1)) 131-141
• 13 Ferrannini E, Natali A, Bell P. et al . Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).  J Clin Invest. 1997;  100 ((5)) 1166-1173
• 14 Fukuchi S, Hamaguchi K, Seike M. et al . Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats.  Exp Biol Med (Maywood). 2004;  229 ((6)) 486-493
• 15 Gardner CD, Kiazand A, Alhassan S. et al . Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial.  JAMA. 2007;  297 ((9)) 969-977
• 16 Griffin MD, Sanders TA, Davies IG. et al . Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study.  Am J Clin Nutr. 2006;  84 ((6)) 1290-1298
• 17 Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F. et al . Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects.  Eur J Clin Nutr. 2007; 
• 18 Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.  Am J Med. 2000;  108 (S 06) S2-S8
• 19 Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.  Diabetologia. 2003;  46 ((1)) 3-19
• 20 Khor GL. Dietary fat quality: a nutritional epidemiologist's view.  Asia Pac J Clin Nutr. 2004;  13 S22
• 21 Lara-Castro C, Garvey WT. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach.  J Clin Endocrinol Metab. 2004;  89 ((9)) 4197-4205
• 22 Mason TM, Goh T, Tchipashvili V. et al . Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.  Diabetes. 1999;  48 ((3)) 524-530
• 23 McAuley K, Mann J. Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance.  J Lipid Res. 2006;  47 ((8)) 1668-1676
• 24 McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.  Diabetes. 2002;  51 ((1)) 7-18
• 25 Moussavi N, Gavino V, Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity?.  Obesity (Silver Spring). 2008;  16 ((1)) 7-15
• 26 Nigam A, Frasure-Smith N, Lesperance F. et al . Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome.  Nutr Metab Cardiovasc Dis. 2008; 
• 27 Oprescu AI, Bikopoulos G, Naassan A. et al . Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo.  Diabetes. 2007;  56 ((12)) 2927-2937
• 28 Pelikanova T, Kazdova L, Chvojkova S. et al . Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients.  Metabolism. 2001;  50 ((12)) 1472-1478
• 29 Raatz SK, Bibus D, Thomas W. et al . Total fat intake modifies plasma fatty acid composition in humans.  J Nutr. 2001;  131 ((2)) 231-234
• 30 Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.  Biomed Pharmacother. 2006;  60 ((9)) 502-507
• 31 Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases.  Exp Biol Med (Maywood). 2008;  233 ((6)) 674-688
• 32 Stein DT, Esser V, Stevenson BE. et al . Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.  J Clin Invest. 1996;  97 ((12)) 2728-2735
• 33 Storlien LH, Higgins JA, Thomas TC. et al . Diet composition and insulin action in animal models.  Br J Nutr. 2000;  83 (S 01) S85-S90
• 34 Storlien LH, Hulbert AJ, Else PL. Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity.  Curr Opin Clin Nutr Metab Care. 1998;  1 ((6)) 559-563
• 35 Storlien LH, Jenkins AB, Chisholm DJ. et al . Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid.  Diabetes. 1991;  40 ((2)) 280-289
• 36 Storlien LH, Oakes ND, Pan DA. et al . Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex.  Diabetes. 1993;  42 ((3)) 457-462
• 37 Tichelaar HY, Spinnler Benade AJ, Daubitzer AK. et al . An improved rapid thin-layer chromatographic-gas-liquid chromatographic procedure for the determination of free fatty acids in plasma.  Clin Chim Acta. 1989;  183 ((2)) 207-215
• 38 Warnotte C, Gilon P, Nenquin M. et al . Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells.  Diabetes. 1994;  43 ((5)) 703-711
• 39 Wilson CR, Tran MK, Salazar KL. et al . Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats.  Biochem J. 2007;  406 ((3)) 457-467
• 40 Winzell MS, Magnusson C, Ahren B. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.  Metabolism. 2007;  56 ((1)) 122-128
• 41 Yaqoob P, Sherrington EJ, Jeffery NM. et al . Comparison of the effects of a range of dietary lipids upon serum and tissue lipid composition in the rat.  Int J Biochem Cell Biol. 1995;  27 ((3)) 297-310

Correspondence